The idea of altering a gene to cure or treat a disease is fairly new, but with the first U.S. approvals of cell and gene therapies in 2017, that concept is now a reality. And the pace of research and development in cell and gene therapy is increasing. A 2018 PhRMA report on the cell and gene therapy pipeline found 289 therapies in clinical development by biopharmaceutical companies in the United States. Today that number is 362.
Get your free copy of the report now.